L'Oreal sales rise as transformation unlocks 'new growth opportunities'

L’Oréal reported full-year sales of €44.05 billion (£38.3 billion), driven by growth across all divisions and regions, with performance accelerating in the second half of the year.

Sales increased by 4% on a like-for-like basis and 1.3% as reported, with e-commerce maintaining double-digit growth and accounting for more than 30% of total revenue.

The Professional Products division posted growth of 7.5% like-for-like and 5.7% reported for the year, with sales exceeding €5 billion (£4.3 billion) for the first time.

Growth was supported by premium haircare and the continued rollout of the division's omnichannel strategy, including accelerated e-commerce and selective distribution.

As part of this, Kérastase recorded double-digit growth, driven by the launch of Gloss Absolu, described as the division’s largest-ever launch. In hair colour, innovation was supported by Matrix Super Sync and the relaunch of Majirel by L'Oréal Professionnel.

The integration of Color Wow also progressed during the year. The acquisition aims to strengthen L’Oréal’s position in the styling segment and support international expansion.

Elsewhere, the Consumer Products division grew 3.5% like-for-like and 0.7% reported, with growth accelerating in the second half, reflecting increased innovation in haircare and makeup.

L’Oréal Paris and NYX Professional Makeup reported "strong" performances, while haircare delivered double-digit growth. Skincare innovation included additions to the Revitalift franchise, such as the Eye Bag Instant Eraser, and Garnier Dry Touch Cream.

L’Oréal Luxe posted growth of 2.8% like-for-like and flat reported growth for the year. Momentum again strengthened in the second half, reaching 3.6%, and close to 5% excluding Travel Retail in Asia, where trading conditions remained "challenging".

Luxe fragrances remained a primary growth driver, particularly within Couture brands. Meanwhile, makeup innovation contributed to growth, and the recently acquired Medik8 strengthened the division’s position in skincare and medicalised beauty.

The Dermatological Beauty division grew 5.5% like-for-like and 2.5% reported. Momentum improved throughout the year, accelerating into double-digit growth in the fourth quarter, supported by alignment between sell-in and sell-out and a gradual turnaround of CeraVe.

La Roche-Posay remained the largest growth contributor, while SkinCeuticals surpassed €1 billion in sales and Vichy recorded growth driven by Dercos and the launch of Collagen Specialist 16.

Nicolas Hieronimus, CEO of L'Oréal, said: "2025 was a defining year for L’Oréal. We delivered strong results regardless of the context, while profoundly transforming the group.

"This transformation opens new growth opportunities, and we are set up for further acceleration. In 2026, despite the macro uncertainties, we are optimistic about the outlook for the global beauty market, and confident in our ability to keep outperforming it thanks to L’Oréal’s multi-division category strategy and to achieve another year of growth in sales and profit."